Treatment of basal cell carcinoma with electrochemotherapy insights from the inspECT registry (2008–2019) /
This prospective registry-based study aims to describe electrochemotherapy (ECT) modalities in basal cell carcinoma (BCC) patients and evaluate its efficacy, safety, and predictive factors. The International Network for Sharing Practices of Electrochemotherapy (InspECT) multicentre database was quer...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2022
|
| Sorozat: | CURRENT ONCOLOGY (TORONTO)
29 No. 8 |
| Tárgyszavak: | |
| doi: | 10.3390/curroncol29080423 |
| mtmt: | 33044025 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26610 |
| LEADER | 02972nab a2200397 i 4500 | ||
|---|---|---|---|
| 001 | publ26610 | ||
| 005 | 20230227113454.0 | ||
| 008 | 230227s2022 hu o 0|| Angol d | ||
| 022 | |a 1198-0052 | ||
| 024 | 7 | |a 10.3390/curroncol29080423 |2 doi | |
| 024 | 7 | |a 33044025 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a Angol | ||
| 100 | 1 | |a Bertino Giulia | |
| 245 | 1 | 0 | |a Treatment of basal cell carcinoma with electrochemotherapy |h [elektronikus dokumentum] : |b insights from the inspECT registry (2008–2019) / |c Bertino Giulia |
| 260 | |c 2022 | ||
| 300 | |a 5324-5337 | ||
| 490 | 0 | |a CURRENT ONCOLOGY (TORONTO) |v 29 No. 8 | |
| 520 | 3 | |a This prospective registry-based study aims to describe electrochemotherapy (ECT) modalities in basal cell carcinoma (BCC) patients and evaluate its efficacy, safety, and predictive factors. The International Network for Sharing Practices of Electrochemotherapy (InspECT) multicentre database was queried for BCC cases treated with bleomycin-ECT between 2008 and 2019 (n = 330 patients from seven countries, with 623 BCCs [median number: 1/patient; range: 1–7; size: 13 mm, range: 5–350; 85% were primary, and 80% located in the head and neck]). The procedure was carried out under local anaesthesia in 68% of cases, with the adjunct of mild sedation in the remaining 32%. Of 300 evaluable patients, 242 (81%) achieved a complete response (CR) after a single ECT course. Treatment naïvety (odds ratio [OR] 0.35, 95% confidence interval [C.I.] 0.19–0.67, p = 0.001) and coverage of deep tumour margin with electric pulses (O.R. 5.55, 95% C.I. 1.37–21.69, p = 0.016) predicted CR, whereas previous radiation was inversely correlated (O.R. 0.25, p = 0.0051). Toxicity included skin ulceration (overall, 16%; G3, 1%) and hyperpigmentation (overall, 8.1%; G3, 2.5%). At a 17-month follow-up, 28 (9.3%) patients experienced local recurrence/progression. Despite no convincing evidence that ECT confers improved outcomes compared with standard surgical excision, it can still be considered an opportunity to avoid major resection in patients unsuitable for more demanding treatment. Treatment naïvety and coverage of the deep margin predict tumour clearance and may inform current patient selection and management. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Muir Tobian |e aut |
| 700 | 0 | 1 | |a Odili Joy |e aut |
| 700 | 0 | 1 | |a Groselj Ales |e aut |
| 700 | 0 | 1 | |a Marconato Roberto |e aut |
| 700 | 0 | 1 | |a Curatolo Pietro |e aut |
| 700 | 0 | 1 | |a Kis Erika |e aut |
| 700 | 0 | 2 | |a Kjaer Lonkvist Camilla |e aut |
| 700 | 0 | 2 | |a Clover James |e aut |
| 700 | 0 | 2 | |a Quaglino Pietro |e aut |
| 700 | 0 | 2 | |a Kunte Christian |e aut |
| 700 | 0 | 2 | |a Spina Romina |e aut |
| 700 | 0 | 2 | |a Seccia Veronica |e aut |
| 700 | 0 | 2 | |a de Terlizzi Francesca |e aut |
| 700 | 0 | 2 | |a Campana Luca Giovanni |e aut |
| 700 | 0 | 2 | |a Kollaborációs szervezet: nspECT BCC Working Group |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/26610/1/curroncol-29-004231.pdf |z Dokumentum-elérés |